Caribou Biosciences Newsroom

Caribou Biosciences Starts Phase 1 Trial for Lupus Drug Candidate

MT NewswiresJan 13 04:47 ET

Express News | Reported Earlier, Caribou Biosciences Advances CB-010, CB-011, And CB-012 Programs With Key Clinical Updates Expected In 2025; Cash Position $281M

BenzingaJan 13 02:33 ET

Caribou Biosciences Initiates Phase 1 Clinical Trials for CB-010 in Lupus and Advances Multiple CAR-T Therapy Programs

Quiver QuantitativeJan 12 19:10 ET

Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025

GlobeNewswireJan 12 19:05 ET

Express News | Caribou Biosciences Initiates the CB-010 Gallop Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025

ReutersJan 12 19:05 ET

BofA Securities Cuts Price Target on Caribou Biosciences to $11 From $13, Maintains Buy Rating

MT NewswiresJan 7 10:40 ET · Ratings

Caribou Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference

Caribou BiosciencesJan 7 00:00 ET

Caribou Biosciences Price Target Raised to $34 From $26 at Brookline

TipRanksJan 6 09:45 ET

Caribou Biosciences Hires CFO From Codexis

WSJJan 2 08:29 ET

Press Release: Caribou Biosciences Appoints Sri Ryali as Chief Financial Officer

Dow JonesJan 2 08:00 ET

Caribou Biosciences Appoints Sri Ryali as Chief Financial Officer

Caribou BiosciencesJan 2 00:00 ET

Why Is Caribou Biosciences Inc. (CRBU) Among the Top CRISPR Stocks to Invest In?

Yahoo FinanceDec 30, 2024 15:01 ET

Here's Why Caribou Biosciences (NASDAQ:CRBU) Must Use Its Cash Wisely

Yahoo FinanceDec 23, 2024 08:59 ET

Caribou Biosciences (CRBU) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Yahoo FinanceDec 16, 2024 09:55 ET

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

BenzingaNov 26, 2024 16:06 ET

Caribou Biosciences Analyst Ratings

BenzingaNov 26, 2024 10:34 ET · Ratings

Citi Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Cuts Target Price to $6

Moomoo NewsNov 26, 2024 07:31 ET · Ratings

Express News | Caribou Biosciences Inc : Citigroup Cuts Target Price to $6 From $30

ReutersNov 26, 2024 06:44 ET

Caribou Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswireNov 20, 2024 16:00 ET

H.C. Wainwright Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsNov 15, 2024 06:34 ET · Ratings